Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Aug;94(2):824–829. doi: 10.1172/JCI117402

Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth.

R Morishita 1, G H Gibbons 1, R E Pratt 1, N Tomita 1, Y Kaneda 1, T Ogihara 1, V J Dzau 1
PMCID: PMC296163  PMID: 8040338

Abstract

In addition to the atria, recent evidence suggests that atrial natriuretic peptide (ANP) is also synthesized in other tissues. Of particular interest is the location of ANP mRNA in the vessel wall. We and others have shown that exogenously added ANP inhibited the growth of endothelial cells and vascular smooth muscle cells (VSMC) in culture. However, it is not known if the locally synthesized ANP would act similarly. Because cultured endothelial cells and VSMC have lost the ability to express the endogenous ANP gene, we have transfected cells in culture with an expression vector expressing rat ANP and have examined the effects on growth. Cultured endothelial cells transfected with an ANP expression vector synthesized and secreted high levels of ANP. These cells also showed significantly lower rates of DNA synthesis under basal and fibroblast growth factor (FGF)-stimulated conditions. Addition of conditioned medium from endothelial cells transfected with ANP vector to nontransfected endothelial cells resulted in the significant increase in cyclic GMP. Similarly, conditioned media collected from endothelial cells transfected with ANP vector also decreased DNA synthesis in VSMC. Coculture of ANP-transfected endothelial cells with quiescent VSMC showed that released ANP from endothelial cells inhibited DNA synthesis in VSMC. Finally, we examined the autocrine effect of direct transfection of ANP vector into VSMC. Transfection of the ANP vector decreased DNA synthesis in VSMC under basal and angiotensin II-stimulated conditions. Similarly, transfection of the ANP vector resulted in a decrease in the PDGF and serum (5%)-stimulated DNA synthesis of VSMC. These results demonstrate that endogenously produced ANP can exert autocrine and paracrine inhibitory effects on endothelial cell and VSMC growth. In vivo gene transfer of ANP may provide us with the opportunity of gene therapy for vascular diseases in which the abnormalities are vasoconstriction and pathological growth.

Full text

PDF
827

Images in this article

826Image
on p.826
826Image
on p.826
827Image
on p.827
827Image
on p.827
828Image
on p.828

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abell T. J., Richards A. M., Ikram H., Espiner E. A., Yandle T. Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. Biochem Biophys Res Commun. 1989 May 15;160(3):1392–1396. doi: 10.1016/s0006-291x(89)80158-5. [DOI] [PubMed] [Google Scholar]
  2. Dagnino L., Drouin J., Nemer M. Differential expression of natriuretic peptide genes in cardiac and extracardiac tissues. Mol Endocrinol. 1991 Sep;5(9):1292–1300. doi: 10.1210/mend-5-9-1292. [DOI] [PubMed] [Google Scholar]
  3. Dichek D. A., Neville R. F., Zwiebel J. A., Freeman S. M., Leon M. B., Anderson W. F. Seeding of intravascular stents with genetically engineered endothelial cells. Circulation. 1989 Nov;80(5):1347–1353. doi: 10.1161/01.cir.80.5.1347. [DOI] [PubMed] [Google Scholar]
  4. Dzau V. J. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes. Curr Opin Nephrol Hypertens. 1993 Jan;2(1):27–32. doi: 10.1097/00041552-199301000-00004. [DOI] [PubMed] [Google Scholar]
  5. Flugelman M. Y., Jaklitsch M. T., Newman K. D., Casscells W., Bratthauer G. L., Dichek D. A. Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter. Circulation. 1992 Mar;85(3):1110–1117. doi: 10.1161/01.cir.85.3.1110. [DOI] [PubMed] [Google Scholar]
  6. Gardner D. G., Deschepper C. F., Baxter J. D. The gene for the atrial natriuretic factor is expressed in the aortic arch. Hypertension. 1987 Jan;9(1):103–106. doi: 10.1161/01.hyp.9.1.103. [DOI] [PubMed] [Google Scholar]
  7. Itoh H., Pratt R. E., Dzau V. J. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990 Nov;86(5):1690–1697. doi: 10.1172/JCI114893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Itoh H., Pratt R. E., Ohno M., Dzau V. J. Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension. 1992 Jun;19(6 Pt 2):758–761. doi: 10.1161/01.hyp.19.6.758. [DOI] [PubMed] [Google Scholar]
  9. Kaneda Y., Iwai K., Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science. 1989 Jan 20;243(4889):375–378. doi: 10.1126/science.2911748. [DOI] [PubMed] [Google Scholar]
  10. Kaneda Y., Iwai K., Uchida T. Introduction and expression of the human insulin gene in adult rat liver. J Biol Chem. 1989 Jul 25;264(21):12126–12129. [PubMed] [Google Scholar]
  11. Kohno M., Yokokawa K., Horio T., Yasunari K., Murakawa K., Takeda T. Atrial and brain natriuretic peptides inhibit the endothelin-1 secretory response to angiotensin II in porcine aorta. Circ Res. 1992 Feb;70(2):241–247. doi: 10.1161/01.res.70.2.241. [DOI] [PubMed] [Google Scholar]
  12. Lemarchand P., Jones M., Yamada I., Crystal R. G. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res. 1993 May;72(5):1132–1138. doi: 10.1161/01.res.72.5.1132. [DOI] [PubMed] [Google Scholar]
  13. Lynch C. M., Clowes M. M., Osborne W. R., Clowes A. W., Miller A. D. Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy. Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):1138–1142. doi: 10.1073/pnas.89.3.1138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Morishita R., Gibbons G. H., Ellison K. E., Nakajima M., Zhang L., Kaneda Y., Ogihara T., Dzau V. J. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8474–8478. doi: 10.1073/pnas.90.18.8474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Morishita R., Gibbons G. H., Kaneda Y., Ogihara T., Dzau V. J. Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest. 1993 Jun;91(6):2580–2585. doi: 10.1172/JCI116496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Morishita R., Gibbons G. H., Kaneda Y., Ogihara T., Dzau V. J. Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells. Hypertension. 1993 Jun;21(6 Pt 2):894–899. doi: 10.1161/01.hyp.21.6.894. [DOI] [PubMed] [Google Scholar]
  17. Nabel E. G., Plautz G., Boyce F. M., Stanley J. C., Nabel G. J. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science. 1989 Jun 16;244(4910):1342–1344. doi: 10.1126/science.2499928. [DOI] [PubMed] [Google Scholar]
  18. Nabel E. G., Plautz G., Nabel G. J. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 1990 Sep 14;249(4974):1285–1288. doi: 10.1126/science.2119055. [DOI] [PubMed] [Google Scholar]
  19. Nakao K., Itoh H., Suga S., Ogawa Y., Imura H. The natriuretic peptide family. Curr Opin Nephrol Hypertens. 1993 Jan;2(1):45–50. doi: 10.1097/00041552-199301000-00007. [DOI] [PubMed] [Google Scholar]
  20. Nakao K., Ogawa Y., Suga S., Imura H. Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides. J Hypertens. 1992 Sep;10(9):907–912. [PubMed] [Google Scholar]
  21. Owens G. K., Loeb A., Gordon D., Thompson M. M. Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol. 1986 Feb;102(2):343–352. doi: 10.1083/jcb.102.2.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rosenzweig A., Seidman C. E. Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem. 1991;60:229–255. doi: 10.1146/annurev.bi.60.070191.001305. [DOI] [PubMed] [Google Scholar]
  23. Suga S., Nakao K., Itoh H., Komatsu Y., Ogawa Y., Hama N., Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". J Clin Invest. 1992 Sep;90(3):1145–1149. doi: 10.1172/JCI115933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Suga S., Nakao K., Mukoyama M., Arai H., Hosoda K., Ogawa Y., Imura H. Characterization of natriuretic peptide receptors in cultured cells. Hypertension. 1992 Jun;19(6 Pt 2):762–765. doi: 10.1161/01.hyp.19.6.762. [DOI] [PubMed] [Google Scholar]
  25. Wilson J. M., Birinyi L. K., Salomon R. N., Libby P., Callow A. D., Mulligan R. C. Implantation of vascular grafts lined with genetically modified endothelial cells. Science. 1989 Jun 16;244(4910):1344–1346. doi: 10.1126/science.2734614. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES